Approximately 30 to 50 new active ingredients are approved in Germany each year. Keeping track and forming a well- informed opinion can be time-consuming and challenging in the daily routine of pharmacy practice. This resource provides comprehensive information on all 41 new pharmaceuticals introduced between December 2023 and November 2024, clearly organised and professionally evaluated. Active ingredient profiles give a clear overview, while detailed graphics illustrate complex modes of action and pathological mechanisms. The author also examines authorisation- relevant studies as well as economic aspects. Each article concludes with an assessment of the thera- peutic relevance and discusses the underlying disease, including its symptoms and previous treatment options, and compares the new active ingredient with its strongest competitors. This allows you to quickly determine whether the new medicinal product represents a groundbreaking innovation or merely an analogue preparation. Target group: Pharmacists in dispensaries and hospitals, physicians in hospitals and practices